Meriden, Conn. (WTNH) – A Meriden-based company says it may have the solution to ineffective flu vaccines.
Protein Sciences manufactures Flublok. The company’s President and CEO Dr. Manon Cox says “a drift in influenza virus strain can effectively be addressed by a strong antibody response. Flublok contains 3X more antigen than traditional trivalent flu vaccines.” The flu usually peaks in February and Flublok is still available.
Recently the Centers for Disease Control and Prevention warned that flu vaccines may be ineffective this year because a new strain of H3N2 influenza virus that is not included in this years’s vaccines is out there.
Cox says his company could begin making an H3N2 vaccine immediately if the Government felt it was necessary and it would be ready in a few months.